Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Oral Probiotics on Ocular Symptoms and Gut Microbiome of Children with Vernal Keratoconjunctivitis: a Double-blind Clinical Trial Study

NCT06793514 is registered in ClinicalTrials.gov with Mohsen Pourazizi as lead sponsor.

NCT NCT06793514
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06793514 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Oral Probiotics on Ocular Symptoms and Gut Microbiome of Children with Vernal Keratoconjunctivitis: a Double-blind Clinical Trial Study
Lead sponsor
Mohsen Pourazizi
Phase
Phase 1
Overall status
Not yet recruiting
Start date
February 1, 2025
Completion date
June 1, 2025
Enrollment
32 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gut -microbiota, gut microbiome dysbiosis, ocular diseases, ocular dryness, ocular surface disease, probiotic